Description
Acquisition Description: This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-04. The North American Industry Classification System (NAICS) code for this procurement is 339112 - SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING (size standard: 1000 employees). The requirement is being competed as a Brand Name or Equal (full and open competition) requirement and is NOT a small business set aside. The Solicitation number is RFQ-CC-24-007623 and the solicitation is issued as a Request for Quotes (RFQ). The National Institute of Health, Clinical Center (NIH-CC) is a clinical research hospital providing all medical services for patients participating in protocols. The Clinical Center conduct Influenza Vaccination "Foil The Flu" Campaign yearly via OMS. The CC Pharmacy department (Program) is responsible for acquiring the supply of Influenza Vaccines (all presentations and strengths) and related supplies required for the Campaign yearly. Program requires 2024-2025 flu vaccines made by Sanofi Pasteur. Program requires this specific brand of Influenza vaccine from Sanofi Pasteur/Sanofi-Pasteur Inc. for older adults and to minimize potential egg allergen reactions. This specific brand has been evaluated/tested by Program to work in its programs such as the “Foil the Flu” campaign and is the best products to use for the patient population they are serving. There will be a requirement for the seller to be direct manufacturers or officially authorized resellers with approval from the manufacturer and with expedited delivery times. This is because program has experienced consistently late in delivering flu vaccines year after year from resellers that add their own lead time onto the manufacturer’s lead time in delivery vaccines. This includes at least one incident when the NIH’s Foil the Flu campaign had to be canceled because of late deliveries. Offerors must be direct manufacturers or authorized sellers capable of 1 week expedited shipping times, and provide this brand of items: 1. 175x units of Fluzone High Dose (10 Prefilled [0.7 mL] BD Luer Lok Syringes); 175x10 doses = 1750 doses; NDC#49281-0124-65; GMID #805799 2. 3x units of Flublok (10 prefilled (.5 mL)); 3x10 doses = 30 doses; NDC#49281-0724-10; GMID #805907 Place of Performance or Delivery: Delivery is estimated to be within one (1) week of award or as soon as possible. Place of Performance: NIH-CC 10 Center Drive Bldg 10, Room 1C166 Attn: Marilyn Farhinre or Fortin Georges Bethesda, MD 20892 The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (SEPT 2023) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (DEC 2022) FAR 52.204-7 System for Award Management (OCT 2018) (Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017) 52.204–26 Covered Telecommunications Equipment or Services-Representation (OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26 The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (DEC 2022) FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (SEP 2023) FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023) FAR 52.204-13 System for Award Management Maintenance (Oct 2018) FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015) 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm. By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. The government intends to award a “firm fixed price” order (in the form of a PO, IDIQ, or BPA) to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The government will evaluate quotes to determine the proposal that conforms to the solicitation and presents the best value to the government (eg. the most advantageous to the Government based on price, performance, availability of funds, etc.). The award will be made based on technical capability to meet the requirements/technical factors, price, and past performance. Submission shall be received not later than 08/21/2024 by @ 4:00 PM EST. Offers may be emailed to Lu Chang at by the date and time stated above. Late submission shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via email to the respective contacts above. Offers shall include RFQ number in the subject line (RFQ-CC-24-007623). Offers shall also include the price, delivery timeframes, and any other required documentation/information as mentioned above. Offers that do not meet these requirements may be excluded from consideration.